Implementation of NCMAG advice 2023 report: October 2024
Posted on:
Document Type
Reports
Summary
These are the results of survey of health boards. It asked if National Cancer Medicines Advisory Group (NCMAG) advice is delivering on supporting equitable access.
Conclusions
These results or show that NCMAG is moving towards its aim. We are supporting the equitable access to safe and effective off-label and off-patent uses of cancer medicines in Scotland. But, there is variation in the medicines governance processes used at board level when considering NCMAG advice.